# The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications

**Authors:** Chad Kerksick, Drew Gonzalez, Jeffery Stout, Scott Forbes, Darren Candow, Tim Ziegenfuss, Robert Marshall, René Schwesig, Richard Kreider

PMC · DOI: 10.1080/15502783.2026.2646627 · 2026-03-23

## TL;DR

Creatine is a well-researched supplement that improves exercise performance, recovery, and health across various populations, including athletes and military personnel.

## Contribution

This review synthesizes decades of research to highlight creatine's broad applications and safety across diverse groups and performance contexts.

## Key findings

- Creatine improves high-intensity exercise performance, lean body mass, and strength through enhanced energy availability.
- Emerging evidence supports creatine's benefits for endurance and team-sport athletes via improved glycogen resynthesis and recovery.
- Creatine is safe, with no greater adverse events than placebo, and may offer neuroprotective and cardiometabolic benefits.

## Abstract

Creatine is one of the most extensively studied ergogenic aids, with over three decades of research supporting its role in exercise performance, recovery, and health.

This narrative review summarizes the historical development of creatine supplementation and evaluates evidence regarding its mechanisms, efficacy across active, athletic populations (e.g. strength, endurance, team-sport), and tactical (e.g. military, law enforcement) populations, and its safety profile.

The evidence suggests that creatine enhances phosphocreatine resynthesis and cellular energy availability, resulting in consistent improvements in high-intensity exercise performance, training adaptations, lean body mass, strength, and power. Additional findings indicate that creatine may attenuate exercise-induced muscle damage and inflammation, support recovery, and improve functional outcomes following strenuous activity. Emerging research suggests benefits for endurance and team-sport athletes through enhanced glycogen resynthesis, calcium handling, oxidative stress mitigation, and repeated-sprint performance. In tactical populations, creatine may support occupational readiness by improving strength, hydration status, thermoregulation, cognition, sleep quality, and recovery, with possible neuroprotective and cardiometabolic implications. Soccer-specific evidence demonstrates improvements in repeated-sprint ability and tolerance to high training loads, with preliminary data suggesting protective effects against neurotrauma and gut barrier disruption. Importantly, pooled analyses from hundreds of clinical trials report no greater incidence of adverse events compared with placebo, reinforcing creatine's established safety profile.

Overall, the evidence suggests that creatine is a versatile supplement with strong evidence to enhance performance and recovery across diverse populations. Future research should prioritize individualized dosing strategies, long-term outcomes in underrepresented groups, and exploration of novel therapeutic applications in health and disease

## Linked entities

- **Chemicals:** creatine (PubChem CID 586)

## Full-text entities

- **Genes:** SLC25A6 (solute carrier family 25 member 6) [NCBI Gene 293] {aka AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y}, TNF (tumor necrosis factor) [NCBI Gene 280943] {aka TNF-a, TNF-alpha, TNFa}, SLC6A8 (solute carrier family 6 member 8) [NCBI Gene 6535] {aka CCDS1, CRT, CRT-1, CRT1, CRTR, CT1}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CALCR (calcitonin receptor) [NCBI Gene 799] {aka CRT, CT-R, CTR, CTR1}
- **Diseases:** cardiometabolic and chronic disease (MESH:D024821), fatigue (MESH:D005221), related (MESH:D019973), neurological symptoms (MESH:D009461), inflammation (MESH:D007249), hypertrophy of skeletal muscle (MESH:C536106), Excess adiposity (MESH:D018205), TBI (MESH:D000070642), head trauma (MESH:D006259), dehydration (MESH:D003681), weight gain (MESH:D015430), sleep deprivation (MESH:D012892), mental health disorders (OMIM:603663), CrM (MESH:C535598), overweight (MESH:D050177), PTSD (MESH:D013313), soreness (MESH:D063806), hypoxia (MESH:D000860), neuroinflammatory (MESH:D000090862), neurotoxicity (MESH:D020258), muscle damage (MESH:D009133), cognitive impairments (MESH:D003072), Parkinson's (MESH:D010300), pain (MESH:D010146), muscle cramping (MESH:D009120), ischaemia (MESH:D007511), headache (MESH:D006261), mitochondrial dysfunction (MESH:D028361), gastrointestinal issues (MESH:D005767), Injury (MESH:D014947), dizziness (MESH:D004244), inflammatory bowel disease (MESH:D015212), concussions (MESH:D001924), obesity (MESH:D009765), depression (MESH:D003866), infarction (MESH:D007238), contusion (MESH:D003288), brain injury (MESH:D001930)
- **Chemicals:** carbohydrate (MESH:D002241), ATP (MESH:D000255), PGE2 (MESH:D015232), glycine (MESH:D005998), P (MESH:D010758), water (MESH:D014867), phosphate (MESH:D010710), reactive oxygen species (MESH:D017382), caffeine (MESH:D002110), glycogen (MESH:D006003), O S (MESH:D009992), glutamate (MESH:D018698), R (MESH:D001120), O P (MESH:C572232), lipid (MESH:D008055), ADP (MESH:D000244), PCr (MESH:D010725), Glycerol (MESH:D005990), CrM (MESH:D003401), P C (MESH:C053518), AlzChem (-), Cr (MESH:D002857), calcium (MESH:D002118), glutamine (MESH:D005973), oxygen (MESH:D010100), lactate (MESH:D019344), C (MESH:D002244), methionine (MESH:D008715)
- **Species:** Ceratomyxa sp. RM (species) [taxon 364902], Equus caballus (domestic horse, species) [taxon 9796], Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13011109/full.md

---
Source: https://tomesphere.com/paper/PMC13011109